The trademark Aurelyxis was filed by Keira Brady, a national of the United States of America (the "Applicant"). The application was published for oppositions on July 31, 2024, and received one opposition filed on October 14, 2024 by Novartis AG on Likelihood of confusion. the opponent was represented by MSA IP d.o.o. and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued October 14, 2024
The application was filed in English, and English was also language of all opposition proceedings (Spanish was selected as the second language).
The Opposition with reference B 003225431 was rejected according to Article 8(1) EUTMDR with decision issued on July 29, 2025 by the EUIPO.
Goods And Services
The mark was filed in class 5 with following description of goods:
Vitamin preparations
Lecithin for medical purposes
Medicinal drinks
Dietary fiber to aid digestion
Haemoglobin
Yeast for pharmaceutical purposes
Nicotine gum for use as an aid to stop smoking
Vitamin tablets
Diet capsules
Medicated candy
Dietetic foods adapted for medical purposes
Dietetic beverages adapted for medical purposes
Acai powder dietary supplements
Dietary supplements
Dietary food supplements
Health food supplements made principally of minerals
Health food supplements made principally of vitamins
Health food supplements for persons with special dietary requirements
Health-aid foods supplements containing ginseng
Food supplements
All the beforementioned excluding pharmaceutical preparations for humans.